Jamshid Gholizadeh Navashenaq2
Immunology, Asthma & Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran.,
Abstracts, Jamshid Gholizadeh Navashenaq2 [Author]
-
MHC class I & II restricted hTERT derived peptides in cancer immunotherapy
Cancer; Prevention, Diagnosis and TreatmentBreast cancer has the highest incidence rate in women in the world. Telomerase is the most common tumor associated antig...Read more